Madrid, here we come! @ESMO2026
We are joining the global oncology community at ESMO 2026, Madrid, and look forward to contributing to the exchange of ideas and innovations shaping the future of cancer care.
#ESMO26#DrReddys#Oncology#DrReddysOncology
We have entered into an exclusive agreement with Takeda to promote and distribute QDENGA®, India’s first CDSCO-approved dengue vaccine, anticipated to be available in the first half of 2027.
Read more: tinyurl.com/48khdxd7#DrReddys#DenguePrevention
Immuno-oncology is opening new possibilities in cancer care. At Abhinandan, G.V. Prasad, leaders and our teams engaged with investigators and advisors on scientific rigor, collaboration, and patient access.
#DrReddys#WeareDrReddys#CancerCare#GoodHealthCantWait
With the first-to-market launch of Sugammadex Injection, a generic equivalent of Bridion®, in the U.S., we continue expanding our hospital portfolio, reinforcing our commitment to improving patient access to affordable, high-quality medicines.
#DrReddys#GoodHealthCantWait
🎉 Exciting news! @drreddys has joined the @AFSAcollab!
We're proud to partner with Dr. Reddy's Laboratories to help advance animal-free science & accelerate the adoption of human-relevant, non-animal methods in drug development & testing.
Welcome to the #AFSAFamily, @drreddys!
As an organization, the cornerstone of our work is closely aligned with our founder’s values, creating access and enabling livelihoods. Our CSR team takes this forward, through initiatives in various areas. #DrReddys#CSR#SpiritOfGiving#GoodHealthCantWait
Launching our 3rd whitepaper, ‘Translational Research Ecosystem: Learnings from the World & Building for India,' from our joint roundtable with Dr. Reddy’s Institute of Life Sciences (DRILS), moderated by Citeline. #GoodHealthCantWait#WeAreDrReddys#TranslationalResearch
We have partnered with Ramdevrao Hospital to establish a Cath Lab in Kukatpally, Hyderabad, expanding local access to advanced cardiac imaging and care , helping address delays in treatment and easing the burden of travel for care. #DrReddys#CSR#HealthcareAccess#CardiacCare
ALT Anuradha Gunupati, Founder Trustee, Dr. Reddy's Foundation, inaugurating facility along with Randhir Kumar, Head Company Secretary & CSR and officials from the hospital
With the first-to-market launch of Bosutinib tablets, 400 mg in the U.S., in collaboration with MSN Laboratories Pvt. Ltd., we are strengthening our oncology portfolio while improving patient access to affordable, high-quality medicines. #WeAreDrReddys#GoodHealthCantWait